КОРРЕКЦИЯ АГРЕГАЦИОННОЙ ФУНКЦИИ ТРОМБОЦИТОВ У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ ПОД ВЛИЯНИЕМ СИМВАСТАТИНА

The application of simvastatine in arterial hypertension patients with metabolic syndrom corrects dislipoproteidemia, peroxidation syndrome, thrombocyte formation and optimized the thrombocyte hemostasis. Simvastatine inhibits decreased adhesive and aggregative function of thrombocytes. For stabilization of the correction results of metabolic processes and thrombocyte hemostasis in arterial hypertension patients with metabolic syndrom the application of simvastatine should be prolonged. With the aim of the decrease of body mass and weakening of insulin resistance in arterial hypertension patients with metabolic syndrom to suppose the combination of simvastatine with inmedicamental threatment.